BNP Paribas Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
51,336
-7,581
| -13% | -$1.66M | 0.03% | 438 |
|
|
2025
Q1 | $13.2M | Buy |
58,917
+19,649
| +50% | +$4.4M | 0.04% | 402 |
|
|
2024
Q4 | $12.9M | Sell |
39,268
-6,956
| -15% | -$2.28M | 0.03% | 414 |
|
|
2024
Q3 | $13.9M | Sell |
46,224
-3,317
| -7% | -$996K | 0.03% | 382 |
|
|
2024
Q2 | $16.3M | Sell |
49,541
-8,159
| -14% | -$2.69M | 0.04% | 334 |
|
|
2024
Q1 | $22.8M | Sell |
57,700
-40,348
| -41% | -$16M | 0.06% | 284 |
|
|
2023
Q4 | $34.5M | Buy |
98,048
+6,395
| +7% | +$2.25M | 0.1% | 234 |
|
|
2023
Q3 | $34.4M | Buy |
91,653
+2,065
| +2% | +$775K | 0.11% | 214 |
|
|
2023
Q2 | $34.3M | Buy |
89,588
+5,344
| +6% | +$2.04M | 0.11% | 211 |
|
|
2023
Q1 | $29.2M | Sell |
84,244
-22,825
| -21% | -$7.91M | 0.1% | 220 |
|
|
2022
Q4 | $25.2M | Buy |
107,069
+3,548
| +3% | +$835K | 0.09% | 259 |
|
|
2022
Q3 | $25.5M | Buy |
103,521
+14,154
| +16% | +$3.48M | 0.1% | 233 |
|
|
2022
Q2 | $27M | Sell |
89,367
-10,203
| -10% | -$3.09M | 0.1% | 224 |
|
|
2022
Q1 | $40.9M | Sell |
99,570
-9,387
| -9% | -$3.86M | 0.14% | 179 |
|
|
2021
Q4 | $51.1M | Buy |
108,957
+39,663
| +57% | +$18.6M | 0.17% | 142 |
|
|
2021
Q3 | $29.4M | Buy |
69,294
+1,339
| +2% | +$568K | 0.11% | 221 |
|
|
2021
Q2 | $24.4M | Buy |
67,955
+30,597
| +82% | +$11M | 0.09% | 270 |
|
|
2021
Q1 | $10.5M | Sell |
37,358
-628
| -2% | -$177K | 0.04% | 405 |
|
|
2020
Q4 | $10.8M | Buy |
37,986
+1,599
| +4% | +$453K | 0.05% | 371 |
|
|
2020
Q3 | $10M | Buy |
36,387
+6,476
| +22% | +$1.78M | 0.06% | 324 |
|
|
2020
Q2 | $6.8M | Buy |
29,911
+6,615
| +28% | +$1.5M | 0.05% | 373 |
|
|
2020
Q1 | $3.55M | Buy |
23,296
+2,628
| +13% | +$400K | 0.03% | 461 |
|
|
2019
Q4 | $3.11M | Buy |
+20,668
| New | +$3.11M | 0.02% | 549 |
|